Articles in this Section
| << Joint Venture | Licensing (248 articles) |
Mergers & Acquisitions >> |
| Next >> |
-
Forest Licenses Novel Diabetes Compounds from TransTech Pharma
-
Pfizer Strengthens Its Position in the Injectables Market
-
Johnson & Johnson Revives Interest in Respiratory Drugs Research
-
Clovis Oncology and Avila Therapeutics to Collaborate on Novel Lung Cancer Drug
-
Orchid in licensing deal with Alvogen
-
Glenmark Inks Two Progressive Deals
-
Celgene and Agios Form a Global Strategic Collaboration to Target Cancer Metabolism
-
Isis Pharmaceuticals Bags USD 35 M Up Front in Deal with GSK
-
Mersana and Teva in USD 334 M deal for preclinical cancer drug
-
Novartis and Array Agree MEK Inhibitor Deal Worth up to USD 467 M



RSS